Shanghai Shyndec Pharmaceutical Co., Ltd. (600420.SS)
CNY 10.23
(-0.87%)
CNY 10.23
(-0.87%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 4.89 Billion CNY | -34.59% |
| 2022 | 7.47 Billion CNY | -14.05% |
| 2021 | 8.7 Billion CNY | 3.19% |
| 2020 | 8.43 Billion CNY | -0.05% |
| 2019 | 8.43 Billion CNY | 5.17% |
| 2018 | 8.02 Billion CNY | 6.62% |
| 2017 | 7.52 Billion CNY | -6.86% |
| 2016 | 8.07 Billion CNY | 219.77% |
| 2015 | 2.52 Billion CNY | 4.5% |
| 2014 | 2.41 Billion CNY | 32.78% |
| 2013 | 1.82 Billion CNY | 42.41% |
| 2012 | 1.27 Billion CNY | 134.68% |
| 2011 | 544.69 Million CNY | 82.76% |
| 2010 | 298.04 Million CNY | 39.12% |
| 2009 | 214.24 Million CNY | 31.11% |
| 2008 | 163.4 Million CNY | 36.66% |
| 2007 | 119.57 Million CNY | 38.8% |
| 2006 | 86.15 Million CNY | -19.24% |
| 2005 | 106.67 Million CNY | 43.54% |
| 2004 | 74.31 Million CNY | -37.6% |
| 2003 | 119.1 Million CNY | 33.98% |
| 2002 | 88.89 Million CNY | 10.19% |
| 2001 | 80.67 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 4.87 Billion CNY | 2.25% |
| 2024 Q2 | 4.76 Billion CNY | -6.33% |
| 2024 Q1 | 5.08 Billion CNY | 4.02% |
| 2023 FY | 4.89 Billion CNY | -34.59% |
| 2023 Q2 | 4.97 Billion CNY | -23.81% |
| 2023 Q4 | 4.89 Billion CNY | 0.76% |
| 2023 Q1 | 6.53 Billion CNY | -12.66% |
| 2023 Q3 | 4.85 Billion CNY | -2.45% |
| 2022 Q2 | 8.58 Billion CNY | -4.44% |
| 2022 FY | 7.47 Billion CNY | -14.05% |
| 2022 Q4 | 7.47 Billion CNY | -4.05% |
| 2022 Q3 | 7.79 Billion CNY | -9.25% |
| 2022 Q1 | 8.98 Billion CNY | 3.29% |
| 2021 Q1 | 9.06 Billion CNY | 7.55% |
| 2021 Q4 | 8.7 Billion CNY | -4.38% |
| 2021 FY | 8.7 Billion CNY | 3.19% |
| 2021 Q2 | 9.62 Billion CNY | 6.1% |
| 2021 Q3 | 9.09 Billion CNY | -5.43% |
| 2020 Q4 | 8.43 Billion CNY | -4.28% |
| 2020 Q1 | 9.05 Billion CNY | 7.29% |
| 2020 FY | 8.43 Billion CNY | -0.05% |
| 2020 Q2 | 8.35 Billion CNY | -7.7% |
| 2020 Q3 | 8.8 Billion CNY | 5.44% |
| 2019 Q4 | 8.43 Billion CNY | -4.89% |
| 2019 Q2 | 9.43 Billion CNY | 18.11% |
| 2019 FY | 8.43 Billion CNY | 5.17% |
| 2019 Q3 | 8.86 Billion CNY | -5.99% |
| 2019 Q1 | 7.98 Billion CNY | -0.4% |
| 2018 Q4 | 8.02 Billion CNY | -3.63% |
| 2018 FY | 8.02 Billion CNY | 6.62% |
| 2018 Q1 | 8.06 Billion CNY | 7.26% |
| 2018 Q2 | 8.31 Billion CNY | 3.04% |
| 2018 Q3 | 8.32 Billion CNY | 0.1% |
| 2017 Q2 | 7.88 Billion CNY | -1.47% |
| 2017 Q1 | 8 Billion CNY | -0.92% |
| 2017 FY | 7.52 Billion CNY | -6.86% |
| 2017 Q4 | 7.52 Billion CNY | -1.8% |
| 2017 Q3 | 7.66 Billion CNY | -2.84% |
| 2016 Q2 | 2.55 Billion CNY | -3.04% |
| 2016 Q1 | 2.63 Billion CNY | 4.18% |
| 2016 Q3 | 2.47 Billion CNY | -3.16% |
| 2016 FY | 8.07 Billion CNY | 219.77% |
| 2016 Q4 | 8.07 Billion CNY | 226.88% |
| 2015 Q2 | 2.74 Billion CNY | 4.06% |
| 2015 Q3 | 2.64 Billion CNY | -3.69% |
| 2015 Q4 | 2.52 Billion CNY | -4.5% |
| 2015 FY | 2.52 Billion CNY | 4.5% |
| 2015 Q1 | 2.63 Billion CNY | 9.18% |
| 2014 Q3 | 2.48 Billion CNY | 1.57% |
| 2014 FY | 2.41 Billion CNY | 32.78% |
| 2014 Q2 | 2.44 Billion CNY | 21.12% |
| 2014 Q1 | 2.02 Billion CNY | 11.08% |
| 2014 Q4 | 2.41 Billion CNY | -2.83% |
| 2013 Q4 | 1.82 Billion CNY | -0.2% |
| 2013 Q3 | 1.82 Billion CNY | 12.29% |
| 2013 FY | 1.82 Billion CNY | 42.41% |
| 2013 Q2 | 1.62 Billion CNY | 11.48% |
| 2013 Q1 | 1.45 Billion CNY | 14.0% |
| 2012 Q4 | 1.27 Billion CNY | 7.5% |
| 2012 Q1 | 554.14 Million CNY | 1.73% |
| 2012 Q2 | 1.14 Billion CNY | 106.79% |
| 2012 FY | 1.27 Billion CNY | 134.68% |
| 2012 Q3 | 1.18 Billion CNY | 3.77% |
| 2011 FY | 544.69 Million CNY | 82.76% |
| 2011 Q4 | 544.69 Million CNY | 16.82% |
| 2011 Q3 | 466.25 Million CNY | 7.81% |
| 2011 Q2 | 432.48 Million CNY | 13.35% |
| 2011 Q1 | 381.54 Million CNY | 28.01% |
| 2010 Q1 | 306.52 Million CNY | 43.07% |
| 2010 Q4 | 298.04 Million CNY | -8.29% |
| 2010 Q3 | 324.97 Million CNY | -4.25% |
| 2010 FY | 298.04 Million CNY | 39.12% |
| 2010 Q2 | 339.38 Million CNY | 10.72% |
| 2009 Q2 | 365.62 Million CNY | 34.57% |
| 2009 Q3 | 315.98 Million CNY | -13.58% |
| 2009 Q4 | 214.24 Million CNY | -32.2% |
| 2009 FY | 214.24 Million CNY | 31.11% |
| 2009 Q1 | 271.7 Million CNY | 66.27% |
| 2008 FY | 163.4 Million CNY | 36.66% |
| 2008 Q4 | 163.4 Million CNY | 8.74% |
| 2008 Q3 | 150.26 Million CNY | 16.29% |
| 2008 Q2 | 129.21 Million CNY | -13.06% |
| 2008 Q1 | 148.61 Million CNY | 24.29% |
| 2007 Q1 | 94.08 Million CNY | 9.21% |
| 2007 Q4 | 119.57 Million CNY | 0.42% |
| 2007 FY | 119.57 Million CNY | 38.8% |
| 2007 Q2 | 111.19 Million CNY | 18.19% |
| 2007 Q3 | 119.06 Million CNY | 7.08% |
| 2006 FY | 86.15 Million CNY | -19.24% |
| 2006 Q3 | 86.87 Million CNY | 27.37% |
| 2006 Q4 | 86.15 Million CNY | -0.83% |
| 2006 Q1 | 93.9 Million CNY | -11.97% |
| 2006 Q2 | 68.2 Million CNY | -27.37% |
| 2005 FY | 106.67 Million CNY | 43.54% |
| 2005 Q2 | 72.01 Million CNY | 2.01% |
| 2005 Q1 | 70.59 Million CNY | -5.01% |
| 2005 Q4 | 106.67 Million CNY | 17.57% |
| 2005 Q3 | 90.73 Million CNY | 25.99% |
| 2004 Q4 | 74.31 Million CNY | -3.29% |
| 2004 FY | 74.31 Million CNY | -37.6% |
| 2004 Q2 | 119.79 Million CNY | 0.0% |
| 2004 Q3 | 76.84 Million CNY | -35.85% |
| 2003 FY | 119.1 Million CNY | 33.98% |
| 2003 Q4 | 119.1 Million CNY | 0.0% |
| 2002 FY | 88.89 Million CNY | 10.19% |
| 2001 FY | 80.67 Million CNY | 0.0% |